FDA Drug Application (077260) for IRINOTECAN HYDROCHLORIDE by TEVA PARENTERAL

Back to FDA Applications sponsored by TEVA PARENTERAL

Application Number077260
Product Number001
FormINJECTABLE; INJECTION
Dosage40MG/2ML (20MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameIRINOTECAN HYDROCHLORIDE
Active IngredientIRINOTECAN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient IRINOTECAN HYDROCHLORIDE3


Back to FDA Applications sponsored by TEVA PARENTERAL